Athens, Greece (ots/PRNewswire) - After 16 years with FAMAR, including the last 4 years as CEO, Konstantinos Rengis decided to step down from his role for personal reasons, effective September 29, 2025. Kostas is widely recognized for his customer-centric approach, deep knowledge of our industry, and his solution-oriented mindset. During his tenure, he played a pivotal role in successfully guiding the company through ...
Europäischer Rechnungshof - European Court of Auditors
Cologne (ots) - Reach MENA (www.reachmena.com), an end-to-end marketing agency targeting affluent Chinese travellers, today announced the European launch of its new brand, TruReach China, the exclusive agent of Alibaba’s Fliggy in Germany as the first move of the expansion in Europe markets. While Chinese ...
Fraunhofer Institut für Angewandte Festkörperphysik IAF
Suresnes, France (ots/PRNewswire) - - Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi company - KER-0193, a novel, orally bioavailable small molecule, was granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA - Acquisition ...
Brussels (ots/PRNewswire) - - 26 scientific abstracts, including two oral presentations, demonstrate UCB's ongoing commitment to advancing research for people living with epilepsies - Data include an open-label extension study describing the long-term safety of FINTEPLA®▼ (fenfluramine)[1] and global functioning ...
Technische Universität München
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE A new biotech hub for Munich Where science powers start-ups: Launching BioLabs|TUM • TUM Venture Labs cooperate with BioLabs and Lilly • 1,800 square meters of coworking lab space • Aiming at accelerating therapy development BioLabs, TUM Venture Labs, and Eli Lilly and Company (Lilly) today launched BioLabs|TUM, a new biotechnology innovation hub in central Munich. The initiative aims to empower early-stage biotech start-ups ...
Many people with cancer experience dramatic loss of muscle and fat tissue. In many cases, even the heart muscle is affected, which further weakens the body. This wasting syndrome, known as cachexia, affects around half of all cancer patients. It is a major cause of therapy resistance, complications, and increased mortality. ...
Tampa, Fla. (ots/PRNewswire) - Aliya Capital Partners and Protego Ventures Co-Lead Strategic Series B Round alongside participating investors: Len Blavatnik's Claltech, Union-Tech Ventures & Chartered Group, as XTEND's AI Robotic Technology Proves Itself in Global Conflicts and the Company Opens Its New U.S. ...
